practitioner
106 results
1 - 100- milrinone
- isoproterenol
- droperidol/fentanyl
- lutein
- bendamustine
- carmustine
- dacarbazine
- gemcitabine
- decitabine
- altretamine
- aldesleukin
- ziv-aflibercept
- denileukin diftitox
- romiDEPsin
- arsenic trioxide
- nelarabine
- DOBUTamine
- floxuridine
- tirofiban
- CARBOplatin
- inamrinone
- phenylephrine
- inotuzumab ozogamicin
- cycloPHOSphamide
- DAUNOrubicin hydrochloride
- chlorambucil
- fludarabine
- labetalol
- thioguanine
- vincristine liposome
- magnesium sulfate (parenteral)
- eptifibatide
- amiodarone
- busulfan
- nesiritide
- etoposide phosphate
- teniposide
- tretinoin (oral)
- dezocine
- tositumomab (I 131 tositumomab)
- DAUNOrubicin citrate liposome
- DOCEtaxel
- pentazocine
- pentostatin
- vinCRIStine
- alfentanil
- etoposide
- anistreplase
- trilaciclib
- cladribine
- epiRUBicin
- esmolol
- mercaptopurine
- norepinephrine
- vinBLAStine
- remifentanil
- trabectedin
- calaspargase
- DACTINomycin
- DOPamine
- trastuzumab
- alteplase
- reteplase
- DOXOrubicin, liposomal
- cabazitaxel
- cytarabine
- streptokinase
- PRALAtrexate
- ado-trastuzumab
- moxetumumab pasudotox
- bleomycin
- tenecteplase
- fluorouracil
- imatinib
- levamisole
- asparaginase Erwinia chrysanthemi
- DOXOrubicin hydrochloride
- CISplatin
- vinorelbine
- abciximab
- metoprolol
- Detecting and Managing Adverse Drug Reactions
- gemtuzumab ozogamicin
- thiotepa
- butorphanol
- fentaNYL (parenteral)
- heparin
- valrubicin
- enfortumab vedotin
- capecitabine
- propranolol
- methotrexate
- Evidence-based Practice and Pharmacotherapeutics
- SUFentanil
- polatuzumab vedotin
- midazolam
- Controlled Substances Schedules
- urokinase
- dasatinib